Lexatin (Bromazepam)

Bromazepam binds to the benzodiazepine site on the GABA‑A receptor, enhancing the natural inhibitory action of GABA. This increased chloride influx reduces neuronal firing, producing calming, anxiolytic, and muscle‑relaxant effects that help alleviate anxiety.

The appropriate dose of Lexatin is determined by the prescribing clinician based on the individual’s medical condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for bromazepam in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against possible risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their physician.

To request Lexatin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lexatin (bromazepam) shares the core anxiolytic properties of other benzodiazepines such as diazepam or lorazepam but differs in potency, half‑life, and metabolic pathways. Bromazepam is often chosen for its intermediate duration of action and relatively predictable pharmacokinetics.

Lexatin should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Lexatin is taken orally, usually as a tablet, with or without food as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include respiratory depression, especially when combined with other CNS depressants, severe allergic reactions, depression or suicidal thoughts, and withdrawal seizures if the medication is stopped abruptly after prolonged use.

Lexatin is contraindicated in patients with known hypersensitivity to bromazepam or other benzodiazepines, those with severe respiratory insufficiency, acute narrow‑angle glaucoma, and individuals who are currently abusing alcohol or other depressants.